Bioage Labs Inc/$BIOA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Bioage Labs Inc
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
Ticker
$BIOA
Sector
Primary listing
Employees
61
Headquarters
Website
Bioage Labs Inc Metrics
BasicAdvanced
$402m
-
-$2.39
-
-
Price and volume
Market cap
$402m
52-week high
$25.96
52-week low
$4.11
Average daily volume
1m
Financial strength
Current ratio
24.759
Quick ratio
24.376
Long term debt to equity
0.588
Total debt to equity
1.064
Interest coverage (TTM)
-211.45%
Profitability
EBITDA (TTM)
-101.47
Gross margin (TTM)
-707.16%
Net profit margin (TTM)
-871.75%
Operating margin (TTM)
-985.93%
Revenue per employee (TTM)
$170,000
Management effectiveness
Return on assets (TTM)
-17.15%
Return on equity (TTM)
-25.98%
Valuation
Price to revenue (TTM)
32.941
Price to book
1.06
Price to tangible book (TTM)
1.06
Price to free cash flow (TTM)
-3.834
Free cash flow yield (TTM)
-26.08%
Free cash flow per share (TTM)
-2.358
Growth
Revenue change (TTM)
610.96%
Earnings per share change (TTM)
-35.11%
Bioage Labs Inc News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.